Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers

被引：0
|
作者：
Neda Stjepanovic
Jan Lubinski
Pal Moller
Susan Randall Armel
William D. Foulkes
Nadine Tung
Susan L. Neuhausen
Joanne Kotsopoulos
Ping Sun
Sophie Sun
Andrea Eisen
Steven A. Narod
机构：
[1] Toronto-Sunnybrook Regional Cancer Center,Department of Genetics and Pathology, International Hereditary Cancer Center
[2] Pomeranian Medical University,Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital
[3] Oslo University Hospital,Program in Cancer Genetics, Department of Oncology and Human Genetics
[4] University Health Network,Division of Biomarkers of Early Detection and Prevention, Department of Population Sciences
[5] McGill University,Dalla Lana School of Public Health
[6] Beth Israel Deaconess Medical Center,undefined
[7] City of Hope,undefined
[8] Women’s College Research Institute,undefined
[9] Women’s College Hospital,undefined
[10] University of Toronto,undefined
[11] BC Cancer Agency,undefined
来源：
Breast Cancer Research and Treatment | 2021年 / 187卷
关键词：
BRCA1; BRCA2; Prospective; Incidence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：515 / 523
页数：8
相关论文
共 50 条
  • [41] The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
    Metcalfe, KA
    Lynch, HT
    Ghadirian, P
    Tung, N
    Olivotto, IA
    Foulkes, WD
    Warner, E
    Olopade, O
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Narod, SA
    GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 222 - 226
  • [42] Cancer risks among BRCA1 and BRCA2 mutation carriers
    Levy-Lahad, E.
    Friedman, E.
    BRITISH JOURNAL OF CANCER, 2007, 96 (01) : 11 - 15
  • [43] Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers
    Lee, Y. C.
    Milne, R. L.
    Lheureux, S.
    Friedlander, M.
    McLachlan, S. A.
    Martin, K. L.
    Bernardini, M. Q.
    Smith, C.
    Picken, S.
    Nesci, S.
    Hopper, J. L.
    Phillips, K. A.
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 114 - 120
  • [44] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [45] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
  • [46] Increased risk of contralateral breast cancer for BRCA1 mutation carriers compared to BRCA2 mutation carriers
    Graeser, M.
    Engel, C.
    Zaino, M.
    Schmutzler, R.
    ONKOLOGIE, 2008, 31 : 28 - 28
  • [47] Breast cancer detection among Irish BRCA1 and BRCA2 mutation carriers.
    Walsh, Elaine
    Farrell, Michael P.
    Gallagher, Fergal
    Clarke, Roisin
    Kennedy, Carmel Nolan M. John
    Daly, Peter
    McCaffrey, John
    Connolly, Elizabeth M.
    Boyle, Terence
    Kell, Malcolm R.
    O'Keefe, Sylvia
    Gallagher, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] BRCA1/2-induced breast cancer risk is not uniform -: Substantial variability in breast cancer risk is observed among BRCA1 and BRCA2 mutation carriers
    不详
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (02) : 147 - 147
  • [49] Breast cancer detection among Irish BRCA1 and BRCA2 mutation carriers.
    Walsh, Elaine
    Farrell, Michael P.
    Gallagher, Fergal
    Clarke, Roisin
    Nolan, Carmel
    Kennedy, M. John
    Daly, Peter
    McCaffrey, John
    Connolly, Elizabeth M.
    Boyle, Terence
    Kell, Malcolm R.
    Gallagher, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [50] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    K Metcalfe
    S Gershman
    H T Lynch
    P Ghadirian
    N Tung
    C Kim-Sing
    O I Olopade
    S Domchek
    J McLennan
    A Eisen
    W D Foulkes
    B Rosen
    P Sun
    S A Narod
    British Journal of Cancer, 2011, 104 : 1384 - 1392
12345